Consensus statement on diabetes control in preparation for pregnancy.

Continuous glucose monitoring: evidence and consensus statement for clinical use.

Continuous glucose monitoring (CGM) is an essential tool for modern diabetes therapy. Randomized controlled studies have provided evidence that hemoglobin A1c (HbA1c) results can be improved in patients with type 1 diabetes with elevated baseline HbA1c when using CGM frequently enough and that the frequency and duration of hypoglycemic events can be reduced in patients with satisfactory baselin...

Correlation of Pre-pregnancy Body Mass Index, Prenatal Weight Gain and Gestational Diabetes – A Case-Control Study

Introduction: Obese and overweight women are more prone to gestational diabetes. Body mass index and weight gain during pregnancy play an important role in pregnancy and is considered as an important indicator of maternal and neonatal health. Because the prevalence of obesity in Yazd is remarkable, we studied the relationship between gestational diabetes with Pre-pregnancy BMI and weight gainin...

American College of Endocrinology and American Diabetes Association Consensus Statement on Inpatient Diabetes and Glycemic Control*

بررسی تأثیر کلاسهای آمادگی دوران بارداری بر سلامت مادر و نوزاد

Since lack of awareness, fear of unknown and also lack of prenatal preparation in pregnant women increase complication of the pregnancy, labor and consequently the medical intervention, this investigation was carried out in order to assess the effectiveness of the preparation classes for pregnancy courses on decrease of complications and medical intervention in pregnant women who refe...

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

OBJECTIVE Several second-generation antipsychotic (SGA) drugs have been associated with weight gain, hyperglycemia, and dyslipidemia. We evaluated whether glucose and lipid testing increased after the American Diabetes Association (ADA) consensus statement recommending metabolic monitoring for SGA-treated patients. RESEARCH DESIGN AND METHODS Laboratory claims for serum glucose and lipid test...